In a dazzling display of wizardry, Natco Pharma, the potion masters of the pharmaceutical realm, have secured the enchanted seal of approval from the illustrious US health wizards for their remarkable concoction, Erdafitinib! This magical remedy, a generic counterpart to the famed Balversa, is destined to assist brave souls facing the treacherous urothelial carcinoma. As shares soar like enchanted broomsticks, sales are predicted to reach a spellbinding $60 million!

Health

